Mark N. Lampert, Director, Ten Percent Owner Other, Director Other at CTI BIOPHARMA CORP (CTIC), sold 17,000,000 shares at $6.12 ($104.0M) on 2022-08-09, disclosed to the SEC on 2022-08-11.
Open-market sale of $104.0M CTIC by Director, Ten Percent Owner Other, Director Other. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.12 | 469,040 | $2.9M | 2.8% |
| 2 | $6.12 | 469,040 | $2.9M | 2.8% |
| 3 | $6.12 | 1,289,434 | $7.9M | 7.6% |
| 4 | $6.12 | 1,289,434 | $7.9M | 7.6% |
| 5 | $6.12 | 2,890,723 | $17.7M | 17.0% |
| 6 | $6.12 | 2,890,723 |
| $17.7M |
| 17.0% |
| 7 | $6.12 | 3,850,803 | $23.6M | 22.7% |
| 8 | $6.12 | 3,850,803 | $23.6M | 22.7% |
| Total | $6.12 avg | 17,000,000 | $104.0M | 100% |
| Filing → |
| XOMA | BUY | 2019-12-20 | $8.2M | — | Filing → |
| CALA | BUY | 2019-11-22 | $1.5M | — | Filing → |
| CALA | BUY | 2019-11-18 | $829K | — | Filing → |